Singapore researchers confirm gene p73's role in tumor growth

June 29, 2015

Singapore, 26 June 2015 - A team of researchers at National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined dual functionality gene p73, in both the promotion and suppression in tumour growth. The NCCS team also receives a S$2.5m grant to aid the research in the next five years.

Early studies have shown that type p73 gene exists as two-major forms: the TAp73 which displays tumour-suppressor functions and the DNp73 form that have been associated with tumour growth activities. While it is known that p73 is related to the master tumour suppressor p53, its role in promoting the growth of tumours is unclear.

Following on the research, the team further explored the tumour-supporting functions of p73 and the correlation with hypoxia, a condition in which tumours are commonly deprived of oxygen in cancers. The findings showed that p73 is stabilised and activated by hypoxic conditions, and promotes efficient blood vessel formation in tumours, which in turn supports the tumour development.

Professor Kanaga Sabapathy, Principal Investigator and Head, Division of Cellular and Molecular Research NCCS said, "Tumours in an oxygen deprived environment acquire genetic alterations that are required in order for the tumour to grow. Our study shows the amount of p73 is elevated in tumours, and correlates with the size and growth of the tumour."

Professor Sabapathy, who has been awarded for the inaugural National Research Foundation's NRF Investigatorship award (Class of 2015), has received S$2.5m grant boost to further the research on the molecular mechanisms of p73. Disbursed over the next five years, he will continue to conduct researches targeting the tumour promotion as well as suppressive functions of p73, opening up the possibilities of restricting the cell growth function of the protein and developing novel treatments for cancer.
The findings were recently published in high impact journal, Nature Cell Biology.


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to